Skip to main content

ABVX · Abivax S.A. · Holdings

Track ABVX — free
$80.60 -3.23 (-3.85%) Q4 2023 earnings call transcript
Market Cap
$7.06B
Shares
87.54M
Volume · Nov 19 2.32M Avg daily vol (3M) 1.11M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 323
Total Value: $5,642,669,245
Total Shares: 57,062,579
+ 1,100,000 shares withheld under SEC confidential treatment, last reported; not in the totals
Showing 1–100 of 367 holdings by value · page 1 of 4

Institutional Ownership Trend

12 quarters

A holder reported that quarter and withheld its positions under SEC confidential treatment, which is not a sale. The line counts it at the shares it last reported; filers usually disclose the real figures about a year later.

Holder Concentration

Share of 13F common-share value, across 323 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
7.4%
Dec 2023 → Sep 2026 · range 7.4% – 22.1%
−3.5 pts
Top 5
31.6%
Dec 2023 → Sep 2026 · range 30.3% – 59.4%
+1.3 pts
Top 10
45.7%
Dec 2023 → Sep 2026 · range 45.0% – 82.1%
+0.6 pts
HHI
293
Dec 2023 → Sep 2026 · range 293 – 995
Broadly held−26

Who Holds ABVX

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 319 filers, like-for-like change +5.7%; actively managed books +6.0%; index-like books +3.0%.

Holder type Share Filers Change
Registered adviser 51.3% 180 +17.0%
Exempt adviser 9.1% 9 +23.3%
Adviser 5.4% 7 +5.7%
Bank 3.0% 18 -44.6%
Insurer 0.5% 1 +18.5%
Broker-dealer 0.3% 3 -53.9%
Benefit plan 0.0% 0 -100.0%
Non-US 0.6% 9 +21.7%
Holding company 7.0% 9 +6.4%
Unknown 22.8% 83 -7.8%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 3 holders with no observed 2026-06-30 13F and 5 holders with no observed 2026-09-30 13F.

Conviction and Crowding

319 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
36
11.3% of filers hold it in their top 10
Jun 30, 2026: 38
Holders above 5%
22
median weight 0.015%
Jun 30, 2026: 27
Crowding
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Top 10 holders
45.6%
of 13F shares, Herfindahl 0.029
Active holders
+6.0%
like-for-like share change of active filers
5% stakes on record
1
0 13D, 1 13G (0 institutional, 1 passive, 0 exempt)
How long holders have held it value-weighted 6.0 quarters
Under 1 year 21.3% 1 to 3 years 64.6% 3 years or more 14.1% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $172,212,595 (29 buying, 21 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$92.37
estimated per share
Jun 30, 2026: $85.37
Quarter-end price
$98.89
implied by 13F values
Estimated gain or loss
+7.1%
price against the estimated cost
Estimated at a loss
58.7%
of costed 13F value

Estimated cost covers 77.4% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ABVX's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 ELVN Enliven Therapeutics, Inc. 24
2 TNGX Tango Therapeutics, Inc. 26
3 MLYS Mineralys Therapeutics, Inc. 20
4 VOR Vor Biopharma Inc. 16
5 COGT Cogent Biosciences, Inc. 26
6 ORKA Oruka Therapeutics, Inc. 23
7 AVTX Avalo Therapeutics, Inc. 19
8 PALI Palisade Bio, Inc. 16
9 CYTK Cytokinetics Inc 27
10 QURE uniQure N.V. 21

Shareholder Targets

13F filers that own its peers but not ABVX, quarter ended Sep 30, 2026

Found through its holder-overlap peers: ELVN, TNGX, MLYS, VOR, COGT, ORKA, AVTX, PALI, CYTK, QURE, PCVX, DRUG, SYRE, TRVI, SGMT, NKTR, TSHA, PRAX, PHVS, ANL. 645 filers in all.

# Filer In peers
1 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $2,502,881,577 5 held
2 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $2,127,636,911 18 held
3 Polar Capital Holdings Plc Registered adviser, Diversified active $1,630,458,674 11 held
4 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $917,122,912 5 held
5 DEERFIELD MANAGEMENT COMPANY, L.P. Registered adviser, Diversified active $793,932,407 6 held
6 Venrock Adviser, LLC Registered adviser, Concentrated $728,823,852 5 held
7 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $602,253,734 6 held
8 Driehaus Capital Management LLC Registered adviser, Diversified active $587,125,797 5 held
9 Capital World Investors Adviser, Diversified active $577,088,351 4 held
10 Fairmount Funds Management LLC Registered adviser, Concentrated $569,893,435 3 held

Fund Ownership of ABVX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.70% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.04% 37,187
Index ETFs 0.66% 578,865
Active ETFs 0.06% 48,671
Active funds 5.61% 4,909,308
Unclassified 0.00% 1,884
All registered funds 6.37% 5,575,915
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
63
Increased
143
Decreased
77
Sold Out
51
Unchanged
37

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +10
Institutional value: -23.0%
Shares held: +3.8%

Institutional value and shares held compare the totals as filed: 1,100,000 shares reported for Jun 30, 2026 by holders that withheld this quarter are left out, and that part of the change is not a sale.

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 367
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 367 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1956827 CUSIP 00370M103 13F (30d) 313 filings 302 filers Visit website Investor relations